Steven Cohen's RCUS Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 3.28 M shares of Arcus Biosciences, Inc. (RCUS) worth $78.16 M, representing 0.09% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in RCUS, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 3.1 M shares. Largest reduction occurred in Q3 2025, reducing 1.63 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Arcus Biosciences (RCUS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Arcus Biosciences (RCUS) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -1.05 M | Reduce 24.29% | 3.28 M | $23.83 |
| Q3 2025 | -1.63 M | Reduce 27.39% | 4.33 M | $13.60 |
| Q2 2025 | +3.1 M | Add 108.11% | 5.97 M | $8.14 |
| Q1 2025 | +870,818 | Add 43.62% | 2.87 M | $7.85 |
| Q4 2024 | -440,794 | Reduce 18.09% | 2 M | $14.89 |
| Q3 2024 | +603,222 | Add 32.89% | 2.44 M | $15.29 |
| Q2 2024 | -81,081 | Reduce 4.23% | 1.83 M | $15.23 |
| Q1 2024 | +1.15 M | Add 149.10% | 1.91 M | $18.88 |
| Q4 2023 | +764,293 | Add 17148.15% | 768,750 | $19.10 |
| Q3 2023 | -705,184 | Reduce 99.37% | 4,457 | $17.95 |
| Q2 2023 | +709,641 | New Buy | 709,641 | $20.31 |
| Q1 2023 | -425,301 | Sold Out | 0 | $0.00 |
| Q4 2022 | +367,467 | Add 635.38% | 425,301 | $20.68 |
| Q3 2022 | +57,834 | New Buy | 57,834 | $26.16 |
| Q2 2021 | -62,926 | Sold Out | 0 | $0.00 |
| Q1 2021 | +62,926 | New Buy | 62,926 | $28.08 |
| Q4 2020 | -194,001 | Sold Out | 0 | $0.00 |
| Q3 2020 | +194,001 | New Buy | 194,001 | $17.14 |
Steven Cohen's Arcus Biosciences Investment FAQs
Steven Cohen first purchased Arcus Biosciences, Inc. (RCUS) in Q3 2020, acquiring 194,001 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Arcus Biosciences, Inc. (RCUS) for 18 quarters since Q3 2020.
Steven Cohen's largest addition to Arcus Biosciences, Inc. (RCUS) was in Q2 2025, adding 5,966,664 shares worth $48.57 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 3,280,000 shares of Arcus Biosciences, Inc. (RCUS), valued at approximately $78.16 M.
As of the Q4 2025 filing, Arcus Biosciences, Inc. (RCUS) represents approximately 0.09% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Arcus Biosciences, Inc. (RCUS) was 5,966,664 shares, as reported at the end of Q2 2025.